Skip to content

Development of standardization for kesharanjan lepa and its clinical management premature graying of hair.

Development of standardization for kesharanjan lepa and its clinical effectiveness in Akala Palitya with special reference to premature graying of hair.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058457
Enrollment
40
Registered
2023-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr. Veena Vitthal More
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: subjects will be selected randomly irrespective of their gender and religion

Exclusion criteria

Exclusion criteria: patients with any skin disorders, hair treated with chemical product and having age below 16 years and above 35 years

Design outcomes

Primary

MeasureTime frame
To develop standard of kesharanjan lepa and to observe its clinical efficacy in Akala palitya.Timepoint: Keshranjan lepa will be applied to hair Schedule - Once in a day Duration - 7 days Follow up - done on 7,14, 21 and 30

Secondary

MeasureTime frame
The clinical efficacy of the study drug will be analysed statistically. If any untoward effect/ ADR observed during trial will be noted in conclusion.Timepoint: Keshranjan lepa will be applied to hair Schedule - Once in a day Duration - 7 days Follow up - done on 7,14, 21 and 30

Countries

India

Contacts

Public ContactDr Veena Vitthal More

Dr.G.D. Pol Foundations Y.M.T Ayurvedic Medical college, hospital and P.G. Institute

drninadsathe03@gmail.com9820274619

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026